Four Component Meningococcal Capsular Group B Vaccine in Preterm Infants

被引:3
|
作者
Sadarangani, Manish [1 ,2 ,3 ,4 ]
Barlow, Sheula [2 ,3 ,4 ]
Anthony, Mark [4 ]
Pollard, Andrew J. [2 ,3 ,4 ]
机构
[1] Univ British Columbia, BC Childrens Hosp, Res Inst, Vaccine Evaluat Ctr, Vancouver, BC, Canada
[2] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England
[3] NIHR Oxford Biomed Res Ctr, Oxford, England
[4] Oxford Univ Hosp NHS Fdn Trust, Dept Paediat, Oxford, England
关键词
ROUTINE INFANT; IMMUNOGENICITY; VACCINATIONS; IMMUNIZATION; RECOMBINANT;
D O I
10.1093/jpids/pix013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:309 / 310
页数:2
相关论文
共 50 条
  • [42] Timing of the First Dose of the Hepatitis B Vaccine in Preterm Infants
    Lei, Donna
    Miller, Taryn
    Carr, Jeremy
    Buttery, Jim
    Nold-Petry, Claudia A.
    Nold, Marcel F.
    Malhotra, Atul
    VACCINES, 2022, 10 (10)
  • [43] Immune response of preterm infants to hepatitis B vaccine.
    AbuLaimoun, BM
    Gelardi, N
    Cashore, WJ
    Oh, W
    Peter, G
    PEDIATRIC RESEARCH, 1996, 39 (04) : 595 - 595
  • [44] Why should the meningococcal B vaccine be recommended, and therefore reimbursed, for infants in France?
    Gras-Le Guen, Christele
    Vignier, Nicolas
    Kochert, Fabienne
    Javouhey, Etienne
    Launay, Elise
    Dufour, Veronique
    Gaudelas, Joel
    Launay, Odile
    Stahl, Jean Paul
    Tattevin, Pierre
    Cohen, Robert
    INFECTIOUS DISEASES NOW, 2021, 51 (05): : 407 - 409
  • [45] Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children
    Castilla, J.
    Garcia Cenoz, M.
    Abad, R.
    Sanchez-Cambronero, L.
    Lorusso, N.
    Izquierdo, C.
    Canellas Llabres, S.
    Roig, J.
    Malvar, A.
    Gonzalez Carril, F.
    Boone, A. L. D.
    Perez Martin, J.
    Rodriguez Recio, M. J.
    Galmes, A.
    Caballero, A.
    Garcia Rojas, A.
    Juanas, F.
    Nieto, M.
    Viloria Raymundo, L. J.
    Martinez Ochoa, E.
    Rivas, A., I
    Castrillejo, D.
    Moreno Perez, D.
    Martinez, A.
    Borras, E.
    Sanchez Gomez, A.
    Pastor, E.
    Nartallo, V
    Arteagoitia, J. M.
    Alvarez-Fernandez, B.
    Garcia Pina, R.
    Fernandez Arribas, S.
    Vanrell, J.
    Garcia Hernandez, S.
    Mendoza, R. M.
    Mendez, M.
    Lopez-Tercero, M. M.
    Fernandez-Rodriguez, A.
    Blanco, A.
    Carrillo de Albornoz, F. J.
    Ruiz Olivares, J.
    Ruiz-Montero, R.
    Limia, A.
    Navarro-Alonso, J. A.
    Vazquez, J. A.
    Barricarte, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (05): : 427 - 438
  • [46] Phase II meningococcal B vesicle vaccine trial in New Zealand infants
    Jackson, C.
    Lennon, D. R.
    Sotutu, V. T. K.
    Yan, J.
    Stewart, J. M.
    Reid, S.
    Crengle, S.
    Oster, P.
    Ypma, E.
    Aaberge, I.
    Mulholland, K.
    Martin, D. R.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2009, 94 (10) : 745 - 751
  • [47] From genes to vaccine: A breakthrough in the prevention of meningococcal group B disease
    Major, Maria
    Moss, Steven
    Gold, Ronald
    PAEDIATRICS & CHILD HEALTH, 2011, 16 (08) : E61 - E64
  • [48] Gonococcal Vaccine Development: Lessons from Group B Meningococcal Vaccines
    不详
    EBIOMEDICINE, 2017, 22 : 1 - 1
  • [50] Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents
    Biolchi, Alessia
    Tomei, Sara
    Santini, Laura
    La Gaetana, Rita
    Mori, Elena
    Novy, Patricia
    Rappuoli, Rino
    Bekkat-Berkani, Rafik
    Giuliani, Marzia Monica
    Pizza, Mariagrazia
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (02) : E66 - E76